#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer recurrent Chronic myeloid leukaemia Thalassaemia Mastocytosis Antiphospholipid antibodies Renal cancer metastatic Oropharyngeal squamous cell carcinoma Splenic marginal zone lymphoma Acute graft versus host disease in skin Pericarditis Pouchitis Short stature homeobox gene mutation Red blood cell abnormality Renal disorder Ventricular tachycardia More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Treatment Mucopolysaccharidosis III Mucopolysaccharidosis II – Life with Disease Haemophilia B with anti factor IX – Diagnostics Inclusion body myositis – Life with Disease Mucous membrane pemphigoid Acute respiratory distress syndrome – Treatment Myelodysplastic syndrome with excess blasts – Diagnostics Retinoblastoma – Diagnostics Advanced systemic mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Isis 678354 Sodium Salt ALLO-QUADCAR01-T Paroxetine Hydrochloride Urapidil Nilotinib Meropenem Nms-03592088 Budesonide Abiraterone Icatibant Degarelix Leniolisib Phosphate Sotorasib Eftrenonacog Alfa ZIMISLECEL Ifezuntirgene Inilparvovec Sodium Hypochlorite Calcium Chloride Dihydrate Zalunfiban Avb-101 More therapies…

    Learn about Your Condition

    Stem cell transplant Neutropenia Craniosynostosis Alcohol use disorder Pulmonary fibrosis Prostate cancer Femur fracture Osteomyelitis acute Dilated cardiomyopathy Post cardiac arrest syndrome Tetanus Diabetic ketoacidosis Carcinoid tumour pulmonary Vulvovaginal candidiasis Arthritis infective More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study to evaluate the effect of EA-230 on the hospital stay length for patients undergoing coronary artery bypass surgery for coronary artery disease.

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • (2S)-2-[[2-[[(2S)-5-AMINO-2-[[(2S)-2-AMINOPROPANOYL]AMINO]-5-OXOPENTANOYL]AMINO]ACETYL]AMINO]-3-METHYLBUTANOIC ACID
    Belgium The Netherlands

  • Evaluating ceftazidime and avibactam with rapid testing for patients with bloodstream infections, hospital-acquired pneumonia, or ventilator-associated pneumonia

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Avibactam
    • Ceftazidime
    Italy

  • A study to evaluate the safety and effectiveness of azetukalner in patients with bipolar depression

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bipolar I disorder
    Investigated Drugs:
    • Azetukalner
    Bulgaria France Germany Spain

  • A study to evaluate the effectiveness of MC0518 (mesenchymal stromal cells) in adults with acute graft-versus-host disease that has not responded to steroids and ruxolitinib

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Acute graft versus host disease
    • Graft versus host disease
    Investigated Drugs:
    • Mesenchymal Stromal Cells, Ex Vivo Cultured
    Italy

  • A study to evaluate the safety and effectiveness of CABA-201, fludarabine, and cyclophosphamide in patients with active inflammatory myopathy

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Caba-201
    • Fludarabine Phosphate
    • Cyclophosphamide Monohydrate
    Germany Italy Spain

  • A study to evaluate the effect of sodium oxybate on sleep quality in adult patients in intensive care units

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Sleep disorder
    Investigated Drugs:
    • Sodium Oxybate
    France
Previous Page
1 … 715 716 717 718 719 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!